康弘药业：收到利非司特滴眼液药品注册证书

Core Viewpoint - Kanghong Pharmaceutical (002773) has received the drug registration certificate for Lifitegrast eye drops from the National Medical Products Administration, marking a significant milestone in the company's product pipeline in the ophthalmology sector [1] Company Summary - The approved Lifitegrast eye drops are indicated for the treatment of signs and symptoms of dry eye, with a formulation of 5% (0.2ml: 10mg) [1] - This product is the first of its kind in China to complete clinical research and obtain market approval, enhancing the company's competitiveness in the ophthalmology market [1]